Trade Bayer ^BAYGn

OTC Pediatric Healthcare Market Report 2025-2031 Featuring Company Profiles of the Leading Players Across the Value Chain; Johnson & Johnson, Bayer, Amway, Sanofi, Procter & Gamble and More - ResearchAndMarkets.com

BAYN: Future Litigation Outcomes And Potential Ag Spin-Out Will Shape Shares

Alaska should ban the herbicide glyphosate in wake of study retraction

Long-term real-world performance of the Bayer Contour TS point-of-care testing glucose meters

Is Bayer (XTRA:BAYN) Quietly Recasting Its Growth Story Around Niche Pharma And Imaging Bets?

Plant Breeding and CRISPR Plants Market Intelligence 2025-2030 Featuring Strategic Analysis of Advanta Seeds, Bayer, Dow, Eurofins, KWS and More

Impact of citrate dialysate on middle molecular weight uremic toxin adsorption and removal in high-flux and MCO dialysis membranes

Has Bayer's 2025 Rally Mispriced Its Long Term Prospects?

Urea use drives niche separation between dominant marine ammonia oxidizing archaea

Herbicide safety article about Monsanto retracted 25 years later - Fast Company

Bayer sues AIG

Scientific article calling glyphosate safe for humans is retracted

Tandem Global e.V. Announces New Supervisory Board Members From AECOM, Bayer, and CRH

U.S. Backs Bayer's Roundup Petition in Supreme Court

Bayer (XTRA:BAYN) Is Up 10.8% After Oncology And Cardio Pipelines Clear Key FDA Hurdles - What's Changed - Simply Wall St News

Further Upside For Bayer Aktiengesellschaft (ETR:BAYN) Shares Could Introduce Price Risks After 27% Bounce

Bayer (0P6S) Receives a Buy from DZ BANK AG | Markets Insider

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations

European shares little changed; Bayer surges on Trump administration backing - The Business Times

US backs Bayer's Roundup petition in Supreme Court | Agri-Pulse Communications, Inc.

Trump admin sides with Roundup maker at Supreme Court

Dow Jones Top Company Headlines at 7 AM ET: Samsung's Next Salvo Against Apple: A Triple-Folding Smartphone | Bayer ... | Morningstar

Morning movers: Trump Administration backs Bayer's Supreme Court bid

Germany's Bayer sees shares pop as US government endorses legal appeal | Euronews

European Midday Briefing: Shares Rebound as Bitcoin Recovers Slightly | Morningstar

Bayer Welcomes Solicitor General Support In Supreme Court Review Of Roundup Case

Trump administration backs Bayer's bid to curb Roundup lawsuits

Trump Official Urges Supreme Court to Take Bayer Roundup Appeal

Bank of America Merrill Lynch | Valuespectrum.com

Bayer's MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

The Black & Yellow schedule for December - Yahoo Sports

BMY Gains Attention as Bayer Reports FXIa Trial Success

Southern rust was the number one yield robbing disease for many growers in 2025 - Brownfield Ag News

Institutions Buying the Dip in Multinational Pharmaceutical Companies' Assets

How Recent Analyst Upgrades Are Shaping the Evolving Story Behind Bayer

BAYN: Future Litigation Decisions And Agriculture Spin-Out Will Guide Shares

stock of the day paytm futures bayer crop targets

Biotech cleared to make biosimilar of $6bn treatment after landmark ruling

Rolfes on Echeverri rumours: "There's no reason to make a decision about it right now" - Yahoo Sports

Luggage mishap stops Bayer Leverkusen plane before Manchester game - Yahoo Sports

Does Bayer's Sharp 42% Rebound Signal Hidden Value After Management Shakeup?

Novo's semaglutide fails in phase III Alzheimer's trials | BioWorld

Bayer's stock is jumping on a stroke drug trial - and so is Bristol Myers Squibb | Morningstar

Correction to Bayer Article | Morningstar

Bayer's stock is jumping on secondary stroke drug's trial success | Morningstar

Bayer's Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention

Bayer's Asundexian Blood Thinner Shows Promising Results After Setback, ETPharma

Bayer's Asundexian Meets Primary Goals In Phase III Study In Secondary Stroke Prevention

Bayer reports positive results for blood thinner after 2023 setback - Yahoo News Canada

Does Bayer's Recent Strategic Update Signal a Real Turnaround Opportunity for 2025?

Evogene Ltd. (NASDAQ:EVGN) Q3 2025 Earnings Call Transcript

Bayer's HER2-mutated lung cancer treatment gets FDA nod | BioWorld

US FDA approves Bayer drug for specific type of lung cancer

First and only FDA-approved treatment for RVO indicated for

Innovation in Action - Soy

Bacterial Vaginosis Market Research Report 2025-2035, Competitive Analysis of Pfizer, Bayer, Exeltis USA, Lupin, Osel

Bayer E-Town Open Innovation Centre launches in Beijing

Accumulate Navin Fluorine International; target of Rs 6441: Prabhudas Lilladher

Bayer launches Alivio, a satellite-enabled agri insurance in collaboration with United India

Bayer launches Alivio, focusing on innovation in the agri-insurance space - The Economic Times

Bayer Aktiengesellschaft (ETR:BAYN) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Long-term evolution of retinal atrophy after focal laser photocoagulation of telangiectatic capillaries: LyoMAC3 study